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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Nε (Hexanoyl)lysine, formed by the reaction of lysine with n 6 lipid
hydroperoxide, is a lipid peroxidation marker during the initial
stage of oxidative stress. The aim of the present study is to
indentify  Nε (hexanoyl)lysine modified proteins in  neoplastic
transformed gastric mucosal cells by N methyl N’ nitro N nitro 
soguanidine, and to compare the levels of these proteins between
gastric mucosal cells and normal gastric cells. Much greater fluo 
rescence of 2 [6 (4' hydroxy)phenoxyl 3H xanthen 3 on 9 yl]benzoic
acid, an index of the intracellular levels of reactive oxygen species,
was observed for gastric mucosal cells compared to normal gastric
cells. Nε (Hexanoyl)lysine modified proteins were detected by SDS 
PAGE or two dimensional electrophoresis and Western blotting
using anti Nε (hexanoyl)lysine polyclonal antibody, and a protein
band of between 30–40 kDa was clearly increased in gastric mucosal
cells compared to normal gastric cells. Two Nε (hexanoyl)lysine 
modified protein spots in gastric mucosal cells were identified as
the tropomyosin 1 protein by mass spectrometry using a MASCOT
search. The existence of Nε (hexanoyl)lysine modification in
tropomyosin 1 was confirmed by Western blotting of SDS PAGE 
separated or two dimensional electrophoresis separated proteins
as well as by the immunoprecipitation with anti tropomyosin 1
antibody. These data indicate that Nε (hexanoyl)lysine modifica 
tion of tropomyosin 1 may be related to neoplastic transformation
by N methyl N' nitro N nitrosoguanidine in gastric epithelial cells.
Key Words: lipid peroxide, gastric cancer, hexanoyl lysine, 
tropomyosin 1
Introduction Several in vivo cancer models support the hypothesis that lipid
peroxidation plays a critical role in experimental carcino-
genesis.(1–3) In chemically induced mammary tumor animal
models, high fat diets are associated with increased tumor inci-
dence, and this effect is diminished by antioxidants (vitamin E and
selenium), observations that would support a role of lipid per-
oxidation.(4,5) Lipid peroxidation under excessive oxidative stress
may play a crucial role in oxidative modification in the process of
carcinogenesis, because reactive lipid-decomposition products
trigger secondary modification of proteins and nucleic acids.
Modification of DNA bases and proteins by reactive aldehydes,
such as 4-hydroxy-2-nonenal (HNE), malondialdehyde, and
acrolein, is thought to contribute to the mutagenic and carcino-
genic effects associated with oxidative stress-induced lipid per-
oxidation.(1) In addition to aldehyde-derived protein modification,
a novel amide-type adduct, Nε-(hexanoyl)lysine (HEL), was chemi-
cally identified from a reaction mixture containing lysine and 13-
hydroperoxyoctadecadienoic acid (13-HPODE).(6) Kato et al.(7)
have demonstrated that HEL is formed by the reaction of lysine
with  n-6 lipid hydroperoxide, which is known to be an early
product of the lipid peroxidation process, suggesting that HEL
might be a lipo-oxidative stress marker during the initial stage of
oxidative stress. HEL has been immunohistochemically identified
in several tissues by using polyclonal or monoclonal antibodies to
HEL.(6,8–11) The excretion of HEL into human urine was confirmed
by liquid chromatography tandem mass spectrometry (LC/MS/
MS).(12) However, there have been no studies investigating the role
of 13-HPODE- or HEL-modified proteins in cancer tissues or cells.
We recently succeeded in the establishment of a novel, trans-
formed cell line (RGK-1) derived from a normal gastric mucosal
cell line (RGM-1) of Wistar rats after treatment with the alkylating
carcinogen  N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).(13)
This cell line showed signs of neoplasia and transformation, in that
it lost contact inhibition and formed tumors in nude mice. RGK-1
cells are the first MNNG-induced neoplastic mutant cells derived
from a noncancerous, nonembryonic gastric epithelial cell line
(RGM-1). This establishment of RGK-1 cells has made it possible
to investigate gastric carcinogenesis using two paired cell lines:
RGM-1 and RGK-1 cells. In the present study, HEL-modified
proteins were detected by two-dimensional polyacrylamide gel
electrophoresis (2D-PAGE) and Western blotting using a novel
monoclonal antibody against HEL, and determined by peptide
mass fingerprinting using MALDI-TOF MS and the MASCOT
search engine by comparing protein spots derived from RGM-1
and RGK-1 cells.
Materials and Methods
Antibodies. Anti-HEL polyclonal antibody was kindly
provided by Professor Yoji Kato (University of Hyogo, Hyogo,
Japan). Tropomyosin-1 (TPM1) monoclonal antibody (D12H4,
XP Rabbit) and Horseradish peroxidase (HRP)-linked anti-rabbit
IgG were purchased from Cell Signaling (Beverly, MA). Anti-
actin antibody was purchased from Abcam Inc. (Cambridge, MA).
HRP-linked anti-rabbit IgG was purchased from Cell Signaling
Technology Inc.
Cell culture. We used the rat gastric mucosal cell line RGM-1
(RCB-0876 at Riken Cell Bank, Tsukuba, Japan), which was
established by Matsui and Ohno,(14) and an MNNG-induced
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mutant of a rat murine RGM-1 gastric epithelial cell line, which
was named RGK-1.(13) Both cells were incubated at 37°C in a
humidified chamber with 5% CO2, and were grown in a 1:1 mix-
ture of Dulbecco’s modified Eagle’s medium/Ham’s F12 medium
(Wako Pure Chem., Osaka, Japan) supplemented with 5% heat-
inactivated fetal calf serum, 1% penicillin and streptomycin. The
cells were subcultured every 3–4 days.
Cellular microscopic fluorescence analysis. RGM-1/RGK-
1 cells were incubated on a Lab-Tec II slide chamber (Nalge Nunc
International, Rochester, NY) at a concentration of 105 cells/mL/
well. Intra-cellular levels of reactive oxygen species (ROS) and
lipid peroxides were investigated with 2-[6-(4'-hydroxy)phenoxyl-
3H-xanthen-3-on-9-yl] benzoic acid (HPF, Wako Pure Chem.)
and diphenyl-1-pyrenylphosphine (DPPP, Dojindo Lab., Kuma-
moto, Japan), respectively.  Cellular fluorescent  images were
observed with a chilled CCD camera (AxioCam color, Zeiss, Jena,
Germany)-mounted epi-fluorescence microscope (Axiovert135M,
Zeiss) connected to an image analyzing system (Axio Vision,
Zeiss). HPF fluorescence was detected with 490 and 515 nm
bandpass filters for excitation and emission, respectively.
Sample preparation for proteomics. Cells were collected
after washing with PBS and were lysed in Lysis buffer (8 M
urea, 4% 3-[(3-cholamidopropyl)dimethylammonio]-1-propane-
sulfonate (CHAPS), 30 mM Tris-HCl). The samples were cen-
trifuged for 20 min at 12,000 × g, 24°C. Contaminants in the
supernatants were removed using a Plus One 2D Clean-up kit
(GE Healthcare UK Ltd., Buckinghamshire, England) according
to the manufacturer’s protocol. Protein concentrations were de-
termined by using a Pierce BCA Protein Assay Kit (Thermo Fisher
Scientific Inc., Waltham, MA).
Western blotting. The protein samples (10 μg) were supple-
mented with NuPAGE LDS Sample buffer containing Sample
Reducing Agent (Invitrogen Japan K.K., Tokyo, Japan) and boiled
for 10 min at 70°C. The protein samples were applied to 12% Bis-
Tris Gels (Invitrogen Japan K.K.) at 200 V for 55 min. IPG strips,
pH 4–7 (Invitrogen Japan K.K.) were rehydrated overnight at
room temperature with rehydration buffer (8 M Urea, 2% CHAPS,
20 mM dithiothereitol, 0.5% ZOOM Carrier Ampholyte 3–10 and
0.002% Bromophenol Blue) containing a 50 μg protein sample.
Isoelectric focusing was performed using a ZOOM IPG Runner
system (Invitrogen Japan K.K., Tokyo, Japan). Isoelectric focusing
was started at 175 V, and the voltage was gradually increased to
2,000 V for 45 min and further held at 2,000 V for 40 min. The
strips were treated with initial equilibration buffer containing
NuPAGE LDS Sample buffer and Sample Reducing Agent for
15 min and a second equilibration buffer containing NuPAGE
LDS Sample buffer and iodoacetamide. The 2-DE was conducted
on NuPAGE 4–12% BisTris Gel at 200 V for 55 min.
The gels of SDS-PAGE and 2-DE were transferred onto nitro-
cellulose membranes (GE Healthcare UK Ltd.). The membranes
were stained with Deep Purple Total Stain (GE Healthcare UK
Ltd.). After blocking with EzBlock (Atto Co., Tokyo, Japan) in
Tris-buffered saline containing 0.1% Tween20 (TBS-T) at room
temperature for 30 min, the membrane was incubated with anti-
HEL polyclonal antibody (1:3,000 dilution in TBS-T), anti-actin
antibody (1:500) and anti-TPM-1 antibody (1:1,500). After incu-
bation in secondary antibodies, the membrane was detected with
an enhanced chemiluminescence (ECL) plus Western Blotting
Reagent (GE Healthcare UK Ltd.) according to the manufacturer’s
instructions.
Protein identification. Protein spots of interest were excised
using an Xcise Proteomics System (Shimadzu Co., Kyoto, Japan)
from the preparative 2-DE gel stained with Coomassie Brilliant
Blue (CBB) (Invitrogen Japan K.K.). Excised spots were washed
with 50 mM ammonium bicarbonate and 50% acetonitrile (ACN)
three times, dehydrated in 100% ACN, and dried. The proteins
were subjected to in-gel digestion with 10 μg/ml trypsin (Pro-
mega) in 50 mM ammonium bicarbonate at 30°C overnight. Tryptic
peptides were extracted from gel slices with 1% trifluoroacetic
acid and 50% ACN. After concentration and desalting by using a
Zip Tip μC18 column (Millipore, Billerica, MA), the resulting
peptides were mixed with an equal volume of 10 mg/ml α-cyano-
4-hydroxycinnamic acid (4-CHCA) (Shimadzu Biotech, Kyoto,
Japan) and peptide mass spectra were obtained using an AXIMA-
CFR plus MALDI-TOF-MASS spectrometer (Shimadzu Co.)
platform for peptide mass fingerprinting (PMF). Protein identifi-
cation was carried out using the MASCOT search engine (http://
www.matrixscience.com/search_form_select.html).
Immunoprecipitation. Immunoprecipitation was performed
using TPM1 antibody and a Protein A HP SpinTrap column (GE
Healthcare UK Ltd.). The TPM1 antibody was incubated with
Protein A Sepharose for 30 min at room temperature. After
washing with PBS buffer, protein samples (800 μg) were incu-
bated with the Protein A Sepharose for 1 h at room temperature.
Immunoprecipitates were washed with PBS and boiled with
NuPAGE LDS Sample buffer (2×) (Invitrogen Japan K.K.) for
10 min at 70°C. Immunoprecipitated proteins were subjected to
Western blotting.
Results
HPF dye fluorescence image. We compared intracellular
bioimages of ROS generation using HPF fluorescence dyes for
RGM-1 and RGK-1 cells. As shown in Fig. 1, the HPF image
showed clear fluorescence in the cytosol around the nucleus.
Much greater fluorescence was observed in RGK-1 cells compared
to RGM-1 cells.
Detection of HEL in proteins from RGM 1 and RGK 1
cells. To detect HEL-modified proteins in RGM-1 and RGK-1
cells, whole proteins from cells were separated by SDS-PAGE or
2-DE, and analyzed by Western blotting using anti-HEL poly-
clonal antibody. As shown in Fig. 2, HEL-modified proteins were
detected in RGM-1 and RGK-1 cells, and the protein band
between 30–40 kDa was increased in RGK-1 cells compared with
RGM-1 cells. Furthermore, as shown in Fig. 3, HEL-modified
protein spots were increased in RGK-1 cells compared with
RGM-1 cells.
Fig. 1. Phase contrast micrographs of RGM 1 cells (a) and mutant
RGK 1 cells (b). HPF fluorescence of RGM 1 cells (c) and mutant RGK 1
cells (d) was detected with 490 and 515 nm bandpass filters for excita 
tion and emission, respectively. J. Clin. Biochem. Nutr. | January 2012 | vol. 50 | no. 1 | 49
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Identification of HEL modified proteins in RGK 1 cells.
To identify the two HEL-modified protein spots in RGK-1 cells,
the protein spots were excised from 2-DE gel stained with CBB,
and analyzed by mass spectrometry. The data obtained using mass
spectrometry (Fig. 4) were searched using the MASCOT search
engine, and both protein spots were identified as the TPM1 protein
with a MASCOT score of 65 and 39% sequence coverage.
Detection of HEL modified TPM1 protein in RGK 1 cells.
To confirm the presence of HEL-modified TPM1 in RGM-1 and
RGK-1 cells, we detected TPM1 and HEL using Western blotting
of SDS-PAGE-separated or 2-DE-separated proteins. As shown
Fig. 5a, the protein band between 30–40 kDa reacted with both
anti-TPM1 antibody and anti-HEL antibody. The TPM1 protein
expression level was increased in RGK-1 cells compared with
RGM-1 cells and was modified by HEL in RGK-1 cells. Moreover,
as shown Fig. 5b, the HEL-modified protein spots reacted with
anti-TPM1 antibody.
To establish the existence of HEL modification of the TPM1
protein, immunoprecipitation with anti-TPM1 antibody was
performed using proteins from RGM-1 and RGK-1 cells, and
the immunoprecipitated proteins were analyzed using Western
blotting with anti-HEL antibody and anti-TPM1 antibody. As
shown Fig. 5c, the TPM1 protein was modified by HEL in RGK-1
cells. Moreover, the TPM1 protein expression level was increased
in RGK-1 cells compared to RGM-1 cells.
Fig. 2. Detection of HEL modified proteins from RGM 1 and RGK 1
cells by SDS PAGE. Protein extracts were separated by SDS PAGE and
were analyzed by Western blotting with anti HEL polyclonal antibody.
Fig. 3. Detection of HEL modified proteins from RGM 1 and RGK 1 cells by 2 DE. Proteins extracts were separated using 2 DE. The 2 DE gels were
transferred onto nitrocellulose membranes and stained with Deep Purple Total Stain to detect total proteins. The membranes were subjected to
Western blotting with anti HEL antibody.doi: 10.3164/jcbn.11 39
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Discussion
In the present study, we observed much greater HPF fluores-
cence in transformed RGK-1 compared to normal gastric mucosal
cells, detected HEL-modified proteins by immunoblotting using
an anti-HEL-antibody, and confirmed that an HEL-modified
TPM1 protein was present only in RGK-1 cells based on peptide
mass fingerprinting using MALDI-TOF MS and the MASCOT
search engine as well as immunoprecipitation. In contrast, the
expression level of TPM1 in RGM-1 was decreased compared to
RGK-1 cells, and HEL-modified TPM1 was not detected. These
data indicate that HEL modification in TPM1 is related to
neoplastic transformation by NMMG in the gastric epithelial
RGM-1 cell line.
To compare the intracellular generation of ROS between the
two cell types, HPF fluorescence was used in the present study.
It has been reported that HPF is a fluorescence dye that clearly
and precisely detects intracellular ROS generation from the
mitochondria.(15) ROS can modify many intracellular signaling
pathways, including protein phosphatases, protein kinases, and
transcription factors, suggesting that the majority of the effects of
ROS occur through their actions on signaling pathways rather
than via non-specific damage of macromolecules. However, the
exact mechanisms by which redox status induces cells to pro-
liferate and how oxidative stress can lead to processes evoking
tumor formation are still under investigation. In the present study,
we first confirmed the increase in HPF fluorescence in RGK-1
cells, and then performed a proteomic analysis to investigate the
molecular targets for oxidative stress.
The proteomic approach has proven very effective in identi-
fying new markers and therapeutic targets as well as in clarifying
disease pathogenesis. To date, the most consistently successful
proteomic methodology is the combination of 2D-PAGE, followed
by protein identification using peptide mass fingerprinting and
tandem MS analysis. As used in the present study. As the relations
between oxidative stress-induced lipid peroxidation and carcino-
genesis become more clearly, protein modification by the products
of lipid peroxidation is attracting increasing attention. To identify
lipid peroxidation-modified proteins in tissues and cells, the
gels of SDS-PAGE or 2-DE are transferred onto nitrocellulose
membranes, and then the proteins can be detected using specific
antibodies against the protein modification. In particular, it has
been reported that 4-HNE can rapidly react with the sulfhydryl
group of cysteine, the amino group of lysine, and the imidazole
group of histidine, which has been shown to result in inactivation
and dysfunction of targeted proteins and enzymes, such as
glyceraldehyde-3-phosphate dehydrogenase,(16) I κB kinase,(17)
tubulin isoforms,(18) Keap1,(19) and heat shock protein (Hsp) 72.(20)
It has also been shown that the formation of HEL is a good marker
for oxidative modification by oxidized n-6 fatty acids such as
linoleic acid and arachidonic acid. Kato et al.(8) evaluated
muscular oxidation injury induced by excessive exercise using a
novel anti-HEL antibody, and showed that flavonoid supple-
mentation clearly reduced the HEL-positivity in muscular tissues,
suggesting that this compound would be useful for reducing
oxidation injury. We also recently demonstrated that HEL-modifi-
cation of carnitine palmitoyltransferase I (CPT I), a rate-limiting
mitochondrial enzyme in the oxidation of fatty acids in muscle,
was increased by exercise, while astaxanthin, an antioxidative
carotenoid, prevented this increase,(21) indicating that the preven-
tion of oxidative modification of CPT I is one of the mechanisms
that might explain the effect of astaxanthin on muscle metabolism.
In the present study, we succeeded in detecting HEL-modified
proteins by immunoblotting using anti-HEL-antibody. Among
these spots, we demonstrated the existence of HEL modification
of TPM1 protein by MALDI-TOF peptide mass fingerprinting
and a MASCOT database search in the 2-DE gel obtained from
RGK-1 cells. To further confirm the presence of HEL-modified
TPM1, we detected TPM1 and HEL by Western blotting in the
protein sample obtained by immunoprecipitation with anti-TPM1
antibody. To the best of our knowledge, TPM1 is the first protein
for which HEL modification has been determined by the 2D-
PAGE and MS.
Although TPM isoforms have been known to function in the
regulation of muscle contraction, the functional significance of
the multiple TPM isoforms present in nonmuscle cells, especially
in cancer cells, remains largely unknown. To date, decreases in
TPM1 expression levels have been reported in human breast
cancer,(22) prostate cancer,(23) and esophageal squamous cell
carcinoma,(24) while increases in TPM1 expression has been
observed in urinary bladder cancer,(25) inflammation-related colon
cancer,(26) and gastric adenocarcinoma.(27) Interestingly, such
opposite expression regulation for different TPM isoforms has
often been found in tumors, implying that these isoforms may
have different functions in cell transformation. These data suggest
that the diametrically opposed regulations of TPM isoforms may
cause an imbalance in normal phenotypes of epithelial micro-
filaments and lead to malignant morphological changes of
aberrant cells.(24)
The most striking observation from the present study was that
HEL-modified TPM1 was identified even though the total protein
levels in transformed gastric cancer cells were higher than those in
normal gastric cells. It has been reported that the regulation of
TPM1 expression appears to be mediated by TPM1 promoter
methylation, histone deacetylation,(28) and microRNA-21.(29,30) In
addition to these regulations, the present study indicates the
Fig. 4. Identification of the HEL modified protein. Proteins from RGK 1 cells were separated by 2 DE and stained with CBB. The spots of interest
were excised and subjected to in gel digestion with trypsin. After the in gel digestion, the peptides were analyzed by AXIMA CFR plus. Mass spectra
were used for protein identification using the MASCOT Search Engine. Both spots were identified as TPM1. J. Clin. Biochem. Nutr. | January 2012 | vol. 50 | no. 1 | 51
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possibility that post-translational modification of the TPM1
protein under excessive oxidative stress may affect its function.
As shown in previous studies, oxidative stress-induced modifica-
tion of several proteins by HNE addition, carbonylation, or
tyrosine nitration impairs their functions.(17,31,32) As shown in our
previous study, HEL modification affected the function of the
CPT1 protein by inhibiting its interaction with cofactor protein
FAT/CD36. The present study extends our knowledge about the
regulation of TPM1, a tumor suppressor protein. Thus, in addition
to epigenetic and translational regulations, TPM1 is also regulated
by post-translational modification. It is our expectation that the
molecular mechanism of HEL modification and the functional
influence of this modification on the TPM1 protein will be
identified in the near future.
Acknowledgments
This work was supported by a Grant-in-Aid for Scientific
Research (B) to T.Y. (No. 21390184), a Grant-in-Aid for Scientific
Research (C) to Y.N. (No. 22590705), and a grant from the City
Area Program to T.Y. and Y.N. from the Ministry of Education,
Culture, Sports, Science and Technology of Japan, and by a grant
from the Adaptable and Seamless Technology Transfer Program
through Target-Driven R&D to Y.N. from the Japan Science and
Technology Agency.
Abbreviations
CAN acetonitrile
4-CHCA α-cyano-4-hydroxycinnamic acid
Fig. 5. Detection of HEL and TPM1 in RGM 1 and RGK 1 cells. Whole proteins from cells were separated by SDS PAGE (a) or 2 DE (b) and analyzed
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CHAPS 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate
CBB Coomassie Brilliant Blue
DPPP diphenyl-1-pyrenylphosphine
2D-PAGE two-dimensional polyacrylamide gel electrophoresis
HEL Nε-(hexanoyl)lysine
13-HPODE 13-hydroperoxyoctadecadienoic acid
HNE 4-hydroxy-2-nonenal
HRP horseradish peroxidase
LC/MS/MS liquid chromatography tandem mass spectrometry
MNNG N-methyl-N'-nitro-N-nitrosoguanidine
PMF peptide mass fingerprinting
ROS reactive oxygen species
TPM1 tropomyosin-1
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